Levine scale
Levine Scale is a medical scale used to assess the severity of chest pain in patients. It was developed by Dr. Samuel A. Levine, a prominent cardiologist, in the early 20th century. The scale ranges from 0 to 5, with 0 indicating no pain and 5 indicating severe pain.
Overview[edit]
The Levine Scale is a simple, yet effective tool for assessing the severity of chest pain. It is often used in conjunction with other diagnostic tools, such as electrocardiograms (ECGs) and blood tests, to determine the cause of the chest pain and the appropriate treatment.
Scale[edit]
The Levine Scale is a six-point scale, with the following levels:
- 0 - No pain
- 1 - Very mild pain
- 2 - Mild pain
- 3 - Moderate pain
- 4 - Severe pain
- 5 - Very severe pain
Usage[edit]
The Levine Scale is primarily used in the assessment of patients with suspected angina pectoris or myocardial infarction (heart attack). It can also be used to monitor the progress of treatment and to assess the severity of pain in other conditions, such as gastroesophageal reflux disease (GERD) and pulmonary embolism.
Limitations[edit]
While the Levine Scale is a useful tool for assessing chest pain, it is not without its limitations. The scale is subjective, meaning it relies on the patient's own perception of their pain. This can lead to variability in scores, as different people have different pain thresholds. Furthermore, the scale does not take into account other symptoms that may accompany chest pain, such as shortness of breath or nausea.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
